Healthcare Archivi - Pagina 4 di 7

7 settembre 2023

Behavioral Health Software Industry Had a Major Share in Subscription Category

The behavioral health software market will power at a compound annual growth rate of 16.10% in the years to come, reaching at a value of USD 9,346 million by 2030.

The industry growth is driven by the increasing requirement for mental wellbeing software, obtainability of government subsidy, and initiatives to power the acceptance of EHRs in psychiatric hospitals. Essentially, the incessant necessity for solutions to advance mental health is the main element powering the expansion of the industry.

The services offered under the behavioral health umbrella comprise those for mental health, alcohol and drug misuse, anxiety, depression, post-traumatic stress ailment, schizophrenia, and eating ailments.

The subscription category accounted for major share in 2022 in the behavioral health software market, and it will power at a rate of about 17% in the years to come. Contrary to large medicinal offices or hospitals, utmost small mental healthcare providers do not have sufficient to send on solutions centered on cutting-edge technologies.

North America dominated the industry with a share of around 42%, in 2022, and it will continue dominating in the years to come. The large share of the U.S. in the region will be because in the number of people needing these services for freedom from mental ailments, surge in the subsidy by the government for their provisioning, and application of numerous behavioral health reforms. Moreover, the easy obtainability of repayment for telepsychiatry services and increasing knowledge of mental health software make the industry a promising industry.

It is due to the increasing occurrence of depression, anxiety, and PSTD, the demand for behavioral health software will continue to grow in the years to come.

4 settembre 2023

Endoscope Reprocessing Industry Will Witness the Fastest Growth in Hospitals

The endoscope reprocessing market size will touch USD 4,277.6 million by 2030, proceeding at a rate of 9.6% by the end of this decade. This is mostly due to the supportive controlling guidelines promoting endoscope reprocessing, growing disease cases requiring endoscopy procedures, and tech progression in reprocessing approaches.

High-level disinfectants and test strips category had about 34% share in 2022, because of the increasing prevalence of numerous endogenous contaminations, for example bacteremia and pneumonia, after endoscopy procedures. Likewise, the acceptance of test strips is growing for the effective measurement of the MEC needed for high-level disinfection, thus delivering faster disinfection reactions.

Furthermore, they support in the discovery of carbohydrates, residual proteins, and hemoglobin on both flexible and rigid endoscopes, via the chart of color comparison.

Reprocessing is mainly done for flexible endoscopes, therefore bringing about their larger share of revenue, of over 65%, in 2022. This is due to the fact that the protuberant players are actively launching AERs that are extremely compatible with flexible endoscopes.

Actually, about 90% of the companies are working on the development of AERs for flexible endoscopes because of their flexibility for controlling and lower weight.

Alterations in the operating environment, for example the increasing stringency of the regulatory necessities associated with reprocessing, are progressing faster than expected. Controlling authorities are taking initiatives for decreasing the chances of HAI’s throughout analysis and treatment.

Hospitals will grow the fastest with around 10% in the years to come in the endoscope reprocessing market. This is because of the increasing count of endoscopy procedures, in addition to the growing count of hospitals at a global level and the declaration of funds and investments delivered by government institutions.

North America led the industry with a share of about 48%, in 2022. This dominance is because of the increasing frequency of tech advancements, increasing elderly populace, snowballing incidence of chronic diseases, particularly gastric ailments; existence of the big names of the industry, improving healthcare services, and snowballing hospital count.

Moreover, the requirement for endoscopies is growing amongst the elderly populace as it is more susceptible to chronic ailments, for example cardiac ailments, blocked arteries, cancer, and GERD. These need GI endoscopies and colonoscopies for their discovery, therefore leading to a surge in the use of endoscopes.

The U.S. is undergoing a demographic shift with the surge in the count of citizens of 65 years or more. According to the U.S. Census Bureau, the age group of people 65 years and older will increase to approximately 24% by 2060.

There is an increase in the number of cases of diseases which require endoscopy procedures, this has a positive impact on the demand for endoscope reprocessing, all over the globe.

1 settembre 2023

European Biomaterials Market is Led by Germany

The biomaterials market will touch USD 349.1 billion by 2030, powering at a rate of 13.4% in the years to come.

The growth of the industry is encouraged by tech progressions, the increasing prevalence of musculoskeletal and skeletal conditions, and increasing support of the governments, such as funds and grants for increasing the production of advanced biomaterials.

The elderly people require extensive care as they are prone to illnesses, as a result of low immunity and high recovery time. As a result of the changes in tendons and ligaments with age, the flexibility of joints decreases, and their motion turn out to be more restricted.

North America biomaterials market had the largest revenue, about USD 50 billion in the past. This is because of the increasing healthcare spending, increasing support of the government, and growing consciousness regarding implantable medical devices.

Germany has a considerable share in Europe, because of the growing requirement for minimally invasive surgeries, high level of patient consciousness, and the existence of cutting-edge healthcare infra for joint replacement surgery.

It is because of the increasing tech-advancements in the field of medical science, the need for biomaterials is on the rise all over the world.

21 agosto 2023

Nerve Repair and Regeneration Industry Development and Demand Forecast to 2030

The nerve repair and regeneration market will reach over USD 17.47 billion, growing at a 12.2% CAGR, by 2030.

The growth of the industry is mainly credited to the increasing incidence of traumatic brain injuries, along with numerous neurological illnesses, for instance, ataxia, Alzheimer’s disease, and acute spinal cord injury. Additionally, the rising government organization’s support for research on nervous system disorders will further boost the growth of the industry in the years to come.

Furthermore, developing nations, such as Brazil, China, and India are providing profitable growth opportunities for the expansion of the domain. This is attributed to the mounting incidence of neurological disorders, increasing healthcare expenses, and the large population in these nations.

In 2021, the neurostimulation/neuromodulation devices category, based on product, accounted for the largest industry share, of over 64%. This is mainly because of the growing commercialized spinal cord stimulation product numbers, itself because of the increasing number of individuals with spinal cord injuries. Additionally, the technological progressions, the biocompatibility of these devices, and the increasing number of applications are boosting the category growth.

The APAC industry will observe the fastest growth rate, of over 13%, in the years to come. This is because of the mounting elderly population, increasing healthcare expenses, and the rising incidence of neurological illnesses, for instance, Parkinson’s, epilepsy, Alzheimer’s, and essential tremors. Additionally, the implementation of advanced technologies for the treatment of these illnesses is boosting the growth in this region.

In APAC, the nerve regeneration and repair therapies adoption in China, Japan, and India is advancing rapidly because of the growing healthcare infrastructure rate and new technology penetrations.

Hence, with the increasing incidence of traumatic brain injuries and rising research on nervous system disorders, the nerve repair and regeneration industry will advance significantly in the coming years.

17 agosto 2023

Robotic Surgery Is Paving Way for a Healthcare Revolution

The global surgical robots market was worth around $6,281.1 million in 2021, which is predicted to touch $30,067.2 million by 2030, growing at a 19% CAGR from 2021 to 2030. This might be related to the rising demand for hip and knee surgery, as well as technical advances. Hospitals reduced or canceled non-urgent outpatient visits during the epidemic. However, with more procedures being performed throughout the world in the future years, the industry is projected to recover and grow more.

Robotic surgery has effectively overcome the constraints of old laparoscopic and thoracoscopic surgeries, enabling more precise execution of complicated and sophisticated surgical operations in a less invasive manner. The surgeon is situated easily on the robotic control console, as opposed to the uncomfortable postures necessary for laparoscopic surgery, which decreases the physician’s physical strain. In addition, as compared to standard laparoscopic devices, manipulating robotic arm instruments enhances the range of motion, allowing the surgeon to conduct more complicated surgical operations.

During the projection period, the surgical robots market is expected to grow at the fastest pace in the neurology category, with a CAGR of roughly 21%. The increasing use of surgical robots for treating patients with tumors and other brain problems can be ascribed to improved technology in robotic brain surgeries and the increasing use of surgical robots for treating patients with tumors and other brain conditions. Furthermore, due to the rising frequency of neurological illnesses and growing need for minimally invasive procedures for executing delicate brain surgeries, the industry in this category is developing.

For example, utilizing DBS technology, the University of California San Francisco devised a way to treat depression symptoms. Electrodes are implanted in the brain to provide electrical currents that change brain function. This form of automated on-demand therapy has a long-term impact on the patient’s condition. Furthermore, in 2021, university researchers produced a new type of voice neuroprosthesis for paralyzed individuals. It will benefit individuals who have a severely injured central nervous system, which can cause paralysis throughout the body.

During the projection period, the APAC surgical robots market is expected to develop at the fastest pace of 20.7%. This can be attributed to rising demand for less invasive procedures to shorten recovery times, a significant presence of international rivals, and increasing robotics advances. Furthermore, prominent firms invest in R & D, to reduce the cost of innovative surgery procedures and accelerate their clinical adoption. In addition, more positive results compared to open procedures, as well as a shorter hospital stay and recovery time for patients, are driving up the need for robotic-assisted surgeries.

Surgical robots have grown in popularity in recent years, both in terms of research and testing, and in terms of use in ordinary treatment including shoulder, foot & ankle, elbow, hand & wrist, and neck. Employing robot arms controlled by a computer, surgeons may perform less invasive treatments with greater precision. Furthermore, as the benefits of minimally invasive surgery become more widely accepted and used, including shorter hospital stays, reduce blood loss, and less pain, new industry participants are launching cost-effective and sophisticated surgical robots.

Hence, the advancing frequency of neurological illnesses and rising demand for minimally invasive treatments are growing for surgical robots.

10 agosto 2023

United States Medical Equipment Maintenance Industry was Dominated by Texas

U.S. Medical Equipment Maintenance Industry

The United States medical equipment maintenance market will power at a rate of 9.2% in the years to come, to reach USD 21,358.3 million by 2030, as stated by a market research institution, P&S Intelligence.

This growth will be driven by the progressions in the medical device industry, increasing consciousness on preventive medical equipment upkeep, and a strict regulatory environment.

Preventive maintenance dominated the industry. This will also have the highest growth rate in the years to come. This can be credited to the growing acceptance of AMC policies by hospitals and other users in the nation, because of the numerous reimbursements related to them.

Private-sector organizations will have the larger share in 2030. This has a lot to do with the budding private-sector healthcare sector and increasing healthcare spending.

Among all the states, Texas dominated the industry in the past, and it is expected to grow the fastest in the years to come.

This is mainly due to the presence of a high number of hospitals in the state, coupled with the growing healthcare expenditure. State agencies, such as the HHSC, DADS, and Texas DSHS, had ~83% of all healthcare expenditure in the state on an annual basis.

The users in the medical equipment maintenance market of the nation are becoming more persuaded toward entering into multi-vendor contracts, for reducing the intricacies and further expenses related to separate services delivered under agreements with the builders of medical equipment.

In the country, numerous tech advanced medical devices and associated products are put to use by healthcare specialists and governments to offer best in-class amenities to patients.

As these high-tech medical devices necessitate steady maintenance, software updates, and other kinds of services, their snowballing acceptance will drive the market in the years to come.

The U.S. has a strict regulatory framework, which makes the maintenance of medical equipment a compulsory requirement for users.

According to the regulations, hospitals must follow OEMs suggest preventive maintenance procedures and programs, unless a waiver was executed and accepted by the health department.

With these kinds of regulations in place, the acceptance of medical equipment upkeep services by hospitals and other healthcare facilities will increase, powering the market in the near future.

This market is highly diversified, because of the occurrence of more than a few key players. Recently, major players have taken a number of strategic measures, for example partnerships, mergers and accusations , and facility developments, to gain a competitive edge in the market.

It is because of the growing consciousness on preventive medical equipment upkeep, the demand for medical equipment maintenance, will increase in the years to come in the U.S.

4 agosto 20234 agosto 2023

APAC To Observe Fastest Growth In the Private Healthcare Insurance Industry

As per a report by P&S Intelligence the healthcare insurance market is growing rapidly, and it will continue like this in the years to come. This is mainly attributed to the increasing elderly population, rising gross domestic product and healthcare expenses, and growing prevalence of chronic illnesses across the world.

Private healthcare insurance companies provide a variety of plans for disease, income protection, and medical. Medical insurance denotes the policy of health insurance that covers high deductible medical expenses. This policy covers specific expenses on a limited amount, for instance, emergency services, ambulatory patient services, and hospital bed expenditures.

Some prominent international players in the private healthcare insurance industry include AXA Group, Allianz SE, Aetna Inc., Aviva plc, Cigna Corporation, Zurich Insurance Group, GIE BNP Paribas Cardif, Continentale Krankenversicherung a.G, Assicurazioni Generali S.p.A., and British United Provident Association Limited. These companies are present in Germany, the U.S., France, Spain, Italy, the United Kingdom, China, Switzerland, Japan, Australia, India, Mexico, and Brazil.

Established in 1890, Allianz SE is an insurance provider that operates in 70 countries worldwide. The company offers insurance products and services through its three main segments: health/life insurance, asset management, and property-casualty insurance.

AXA Group, established in 1982, is an insurance company that operates across six distinct segments: Asia, France, the U.S., Europe, transversal and central holdings, and international. The group provides a wide range of products and services across multiple categories, including life and savings, health, property and casualty, banking, and asset management.

The U.S., China, India, Japan, France, Germany, Italy, the U.K., Spain, Switzerland, Australia, Mexico, and Brazil have well-established insurance networks of international players. Additionally, government-mandated insurance policies play a crucial role in driving the growth of both the private and public healthcare insurance industry.

The global private healthcare insurance industry will observe the fastest growth in APAC, particularly in China, India, Australia, and Japan. This growth can be attributed to several factors, such as the increasing healthcare insurance industry, the mounting incidence of chronic illnesses, and rising consciousness regarding healthcare in the region. The growth of the medical tourism industry also contributes to the development of the industry in APAC.

Some of the key players in APAC include Allianz SE, AXA Group, Ping An Insurance (Group) Company of China Ltd., China Life Insurance Co. Ltd., Aetna International, Nippon Life Insurance Company, Allianz SE, Star Health & Allied Insurance Company Limited, Religare Health Insurance Company, and ICICI Lombard General Insurance.

Moreover, the overall dynamics of the healthcare insurance industry in the APAC are undergoing significant changes, driven by improvements in healthcare infrastructure and expenses. As a result, healthcare insurance plans are becoming popular among people in Asia.

Hence, with the increasing elderly population and mounting prevalence of chronic illnesses across the world, the industry of private healthcare insurance will continue to grow in the years to come.

2 agosto 2023

Medical Gloves Industry To Observe Fastest Growth In Asia-Pacific

As per a statement by P&S Intelligence, the medical gloves industry will reach USD 20,435.6 million, propelling at a rate of 10.8%, by 2030.

The growth in the industry is credited to the increasing elderly population, the growing risk of contagious diseases, mounting healthcare expenses, the growing volume of surgeries, and the increasing incidence of chronic diseases.

The medical gloves industry had been positively affected by the COVID-19 pandemic, due to the sudden surge in medical supplies demand.

Based on raw materials, the nitrile category held the largest share of the medical gloves industry in recent years. This is mainly due to its non-allergic properties.

North America is expected to dominate the industry in the years to come, owing to the widespread necessity for medical gloves in healthcare units, and the existence of strong key players.

Moreover, APAC is expected to witness the fastest growth in the coming years, owing to the increasing elderly populace and rising number of surgical procedures and diagnostic examinations.

A key trend observe in the industry is the fondness for non-powdered medical gloves over powdered medical gloves by the customers, due to the non-allergic properties of the non-powdered medical gloves.

In the past few years, players in the industry have been involved in product launches and mergers & acquisitions to maintain a competitive edge.

Hence, due to the increasing elderly pullulation, increasing incidence of chronic diseases, and growing risk of contagious diseases, the medical gloves industry will continue to grow significantly in the years to come.

28 luglio 2023

Benign Prostatic Hyperplasia Treatment Industry Growth and Forecast Report 2023-2030

The benign prostatic hyperplasia treatment market will reach USD 18,837.7 million in 2030, with a CAGR of 5.2% in the years to come. The increasing occurrence of BPH, surging preference for minimally invasive surgeries, and growing investments, funds, and grants for conducting research on novel treatments are the protruding contributors to the development.

The larger share, around 85%, was held by drugs. This is because of the growing requirement for alpha-blockers as these medicines relax the muscle of the prostate and bladder neck, enabling urine flowing more easily.

Amongst the diverse types of drugs, alpha-blockers have been extensively used for treating the disease recently. Their increasing usage and the abundance of medicines under expansion present potential prospects for the industry.

Home healthcare settings had the larger share, and they will record the higher rate, over 5%, in the years to come, as a result of the growing patient count prescribed drugs over surgical treatment.

North America dominated the BPH treatment market with 41% share, as stated by a market research firm, P&S Intelligence. The increasing occurrence of the problem is powering the acceptance of cutting-edge treatments, for example, prostatic stenting, laser therapy, and UroLift therapy, thereby powering the development of the industry in the region.

APAC will grow the fastest in the years to come, at a rate of 6.4%. The improving standards of living, increasing per capita income and spending ability, snowballing burden of urological disease, and increasing investment in the healthcare for boosting the progress.

Furthermore, the increasing aging male population, together with a boom in the occurrence of obesity and diabetes, will power the prevalence of BPH and other lower urinary tract conditions.

China, India and Japan together have a large aging male population, requiring regular medical assistance, being extremely susceptible to chronic ailments as a result of its low immunity.

Therefore, patients with an irregular growth of the prostate are needed to be treated, to prevent urethra blockage and decrease the related cancer risk.

The increasing elderly male population is the main reason for the growing demand for BPH treatment all over the world.

27 luglio 2023

North America Is Dominating Professional Acne Treatment Industry

The global professional acne treatment market is experiencing growth and is projected to reach USD 13,124.5 million by 2030. This development can be credited to the increasing occurrence of acne, rising per-capita income in emerging and emerging nations, growing healthcare expenditure, and the rising count of research events.

In recent years, Inflammatory acne had the largest industry share, on the basis of acne type. This is mainly because of the instant need for better-quality treatment as it is normally painful.

Additionally, the generally accessible salicylic acid and benzoyl-peroxide-based over-the-counter items are not completely effective on inflammatory spots. Then, branded and common medications are provided by key medicinal businesses, on prescription, for inflammatory spots.

In the coming few years, the devices category is projected to experience faster development in the professional acne treatment industry, on the basis of treatment type. This can be ascribed to the increasing acceptance of light-based and laser acne treatments, largely in advanced countries, credited to the side effects of medications.

On the basis of professional type, in recent years, the dermatologist’s category is projected to dominate the professional acne treatment industry. This is mainly because of the growing count of expert dermatologists treating skin illnesses, like acne. Moreover, patients choose dermatologists due to their wide expertise and experience in dealing with the issue.

In recent years, North America led the industry, mainly because of the increasing occurrence of acne, growing knowledge of afresh developed medications, the huge pipeline of medications, and high per-capita income in the continent.

Furthermore, the continent is marked by the existence of protuberant dermatology medication producers, including Pfizer Inc., Johnson & Johnson, and Bausch Health Companies Inc., who offer several classes of medications to the North American populace.

Several pharmaceutical businesses are introducing new products, which have become a key trend in the industry for expert acne treatment items. For example, in 2020, Cassiopea SpA got the U.S. Food and Drug Administration (FDA) sanction for Winlevi, a clascoterone-founded cream made for the cure of acne in patients 13 years and elder.

Furthermore, AnnJi Pharmaceutical Co. Ltd. is involved in the growth of AJ101, which is an up-to-date cream formulation for the cure of acne vulgaris. The active element in AJ101 is a new androgen receptor degradation enhancer, which efficiently reduces the level of activity.

Individuals are concentrating on improving their looks by actively spending on a wide-ranging skincare regimen for scars, acne, and other skin issues. There are numerous treatment choices obtainable, such as systemic agents, topical therapies, lasers, physical modalities, and photodynamic therapy.

Hence, the increasing occurrence of acne, rising per-capita income in emerged and emerging nations, growing healthcare expenditure, and the rising count of research events are the major factors propelling the professional acne treatment market.